Maynard Um
-
-
-
-
-
-
-
Adverum Biotechnologies (ADVM) PT Raised at RBC Capital To Reflect Proposed LLY Acquisition
-
-
-
-
-
-
-
Adverum Biotechnologies (ADVM) PT Lowered to $5 at RBC Capital, Reflecting Increased OpEx
-
-
-
-
-
-
-
Adverum Biotechnologies (ADVM) PT Lowered to $10 at RBC Capital
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Adverum Biotechnologies (ADVM)
-
-
-
-
-
-
-
Adverum Biotechnologies (ADVM) Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for Ixo-vec for the Treatment of Wet AMD
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

